• PBTLI is your CRO for efficient preclinical testing.
    PBTLI provides rapid pre-clinical testing to pharmaceutical, biotechnology, and medical device companies for facilitating new product development.
Welcome   to PBTLI

Prime Behavior Testing Laboratories Inc. is a US-based company that serves to assist clients with the testing and evaluation of novel therapeutic agents and to identify products that may be suitable for clinical trials in an efficient and cost-effective manner. We specialize in cognition testing (Learning, Memory, and Attention) in rodent and Non-Human Primates (NHPs).


We help identify products that may be suitable for clinical trials.

We test the efficacy of novel therapeutics for cognitive and psychiatric disorders. We also test drugs for abuse potential and abuse prevention.

We specialize in cognitive testing (Learning, Memory, and Attention)

Tests on rodent and Non-Human Primates are overseen by a full-time academic who runs the small animal core facility. We stay current due to ongoing scientific research studies in animal behavior.


PBTLI is unique from most other clinical research organizations - we provide specialized attention and cater our research specifically to your company's needs.

  • 1
    Qualified Staff
    Our staff consists of highly trained animal behavior technicians, some with 20+ years of industry experience.
  • 2
    Academic Affiliation
    PBTLI is affiliated with the Animal Behavior Center at Augusta University.
  • 3
    Well Published
    We continually produce new scientific literature and publish in top, peer reviewed scientific journals. This underscores our emphasis on innovation and new science.
  • 4
    Focused Facility
    We are a smaller facility; however, we focus on customer service, efficiency, and reliability.
  • 5
    Wide Range of Services
    While we specialize in animal behavior, we can provide the most basic (e.g., cell-culture) evaluations to pre-clinical NHP testing and scientific advising.
  • 6
    Results You Can Trust
    We will provide a frank, honest, and unbiased assessment of your novel therapeutic agent or technology. We can provide detailed SOPs for all of the services we offer and have a large database of positive control compounds for efficacy comparisons.

Latest News

  • New Journal Article Published:
    α7 Nicotinic Acetylcholine Receptors as Therapeutic Targets in Schizophrenia: Update on Animal and Clinical Studies and Strategies for the Future.
    Published: 2020 Mar 15

    Abstract: Schizophrenia is a devastating mental illness and its effective treatment is among the most challenging issues in psychiatry. The symptoms of schizophrenia are heterogeneous ranging from positive symptoms (e.g., delusions, hallucinations) to negative symptoms (e.g., anhedonia, social withdrawal) to cognitive dysfunction. Antipsychotics are effective at ameliorating positive symptoms in some patients; however, they are not reliably effective at improving the negative symptoms or cognitive impairments. The inability to address the cognitive impairments is a particular concern since they have the greatest long-term impact on functional outcomes....

    View Article

  • More About PBTLI

    PBTLI is a pre-clinical contract research organiztion (CRO) that provides rapid pre-clinical testing to pharmaceutical, biotechnology, and medical device companies for facilitating new product development.

  • Need a Quote?

    Please visit our contact page to get in touch.

    Get a Quote
  • Latest News

    • New Journal Article Published:

      Crider A, Nelson T, Davis T, Fagan K, Vaibhav K, Luo M, Kamalasanan S, Terry AV Jr, Pillai A. Estrogen Receptor β Agonist Attenuates Endoplasmic Reticulum Stress-Induced Changes in Social Behavior and Brain Connectivity in Mice. Molecular Neurobiology 55(9):7606-7618, 2018.

Copyright ©2019 Prime Behavior Testing Laboratories, Inc
^ Back to Top